GlassScriptPhysician profile
Holly Brehm
NPI 1447708227
$3,929.19
in general payments reported to CMS, 2019-2025
13 companies · $605 in 2025
The $605 reported for 2025 was more than what 75% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $184 · 2022: $63.82 · 2023: $458 · 2024: $2,618 · 2025: $605.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,099 · Travel and Lodging: $1,453 · Education: $130.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,098.59 |
| Travel and Lodging | $1,453.18 |
| Education | $130.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $2,278.42 | 2021-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Abbott Laboratories | $412.78 | 2021-2025 | Mitraclip, Thoratec Heartmate 3 Lvas Implant Kit, Aveir |
| Novartis Pharmaceuticals Corporation | $277.03 | 2024-2025 | |
| Boston Scientific Corporation | $221.16 | 2021-2025 | Watchman Access System, Farapulse, Watchman Flx |
| Astrazeneca Pharmaceuticals LP | $217.24 | 2024-2025 | Farxiga |
| E.R. Squibb & Sons, L.L.C. | $148.78 | 2023-2025 | Camzyos, Cobenfy, Eliquis |
| Abiomed | $107.87 | 2024-2025 | Impella |
| Janssen Pharmaceuticals, INC | $100.44 | 2023-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $44.78 | 2021-2024 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $42.00 | 2021-2024 | Jardiance |
| Medtronic, INC. | $32.30 | 2025 | Aurora Ev-Icd Mri Surescan |
| Pfizer INC. | $28.88 | 2022-2024 | |
| Chiesi USA, INC. | $17.51 | 2024 | Cleviprex, Kengreal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Holly Brehm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.